nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—OPRK1—Progesterone—uterine cancer	0.188	0.304	CbGbCtD
Mirtazapine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0813	0.132	CbGbCtD
Mirtazapine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0567	0.0918	CbGbCtD
Mirtazapine—CYP2C8—Progesterone—uterine cancer	0.0539	0.0871	CbGbCtD
Mirtazapine—CYP1A2—Progesterone—uterine cancer	0.0417	0.0675	CbGbCtD
Mirtazapine—CYP2C9—Progesterone—uterine cancer	0.0376	0.0608	CbGbCtD
Mirtazapine—CYP2D6—Progesterone—uterine cancer	0.0344	0.0556	CbGbCtD
Mirtazapine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.033	0.0534	CbGbCtD
Mirtazapine—CYP2C8—Etoposide—uterine cancer	0.0241	0.039	CbGbCtD
Mirtazapine—CYP3A4—Progesterone—uterine cancer	0.0219	0.0353	CbGbCtD
Mirtazapine—CYP1A2—Etoposide—uterine cancer	0.0187	0.0302	CbGbCtD
Mirtazapine—CYP2D6—Doxorubicin—uterine cancer	0.0105	0.017	CbGbCtD
Mirtazapine—CYP3A4—Etoposide—uterine cancer	0.00978	0.0158	CbGbCtD
Mirtazapine—CYP3A4—Doxorubicin—uterine cancer	0.00667	0.0108	CbGbCtD
Mirtazapine—HTR7—artery—uterine cancer	0.00211	0.0469	CbGeAlD
Mirtazapine—HTR2A—artery—uterine cancer	0.00131	0.0293	CbGeAlD
Mirtazapine—HTR2B—myometrium—uterine cancer	0.00119	0.0265	CbGeAlD
Mirtazapine—OPRK1—female reproductive system—uterine cancer	0.00118	0.0263	CbGeAlD
Mirtazapine—ADRA2C—myometrium—uterine cancer	0.000935	0.0208	CbGeAlD
Mirtazapine—HTR2B—uterine cervix—uterine cancer	0.000925	0.0206	CbGeAlD
Mirtazapine—HTR2B—smooth muscle tissue—uterine cancer	0.000899	0.02	CbGeAlD
Mirtazapine—HTR2B—decidua—uterine cancer	0.000881	0.0196	CbGeAlD
Mirtazapine—HTR2B—endometrium—uterine cancer	0.000836	0.0186	CbGeAlD
Mirtazapine—HTR7—epithelium—uterine cancer	0.000799	0.0178	CbGeAlD
Mirtazapine—SLC6A2—decidua—uterine cancer	0.000783	0.0174	CbGeAlD
Mirtazapine—HTR1A—renal system—uterine cancer	0.000775	0.0173	CbGeAlD
Mirtazapine—HTR2B—uterus—uterine cancer	0.000771	0.0172	CbGeAlD
Mirtazapine—ADRA1A—epithelium—uterine cancer	0.00077	0.0172	CbGeAlD
Mirtazapine—HTR7—smooth muscle tissue—uterine cancer	0.000769	0.0171	CbGeAlD
Mirtazapine—HRH1—myometrium—uterine cancer	0.00076	0.0169	CbGeAlD
Mirtazapine—ADRA2A—myometrium—uterine cancer	0.000746	0.0166	CbGeAlD
Mirtazapine—HTR7—renal system—uterine cancer	0.000741	0.0165	CbGeAlD
Mirtazapine—HTR2C—female reproductive system—uterine cancer	0.000737	0.0164	CbGeAlD
Mirtazapine—ADRA2C—uterine cervix—uterine cancer	0.000728	0.0162	CbGeAlD
Mirtazapine—ADRB1—female reproductive system—uterine cancer	0.000724	0.0161	CbGeAlD
Mirtazapine—ADRA1A—renal system—uterine cancer	0.000714	0.0159	CbGeAlD
Mirtazapine—SLC6A4—female reproductive system—uterine cancer	0.000699	0.0156	CbGeAlD
Mirtazapine—ADRA2C—decidua—uterine cancer	0.000693	0.0154	CbGeAlD
Mirtazapine—HTR2B—female reproductive system—uterine cancer	0.000693	0.0154	CbGeAlD
Mirtazapine—ADRA2C—renal system—uterine cancer	0.000681	0.0152	CbGeAlD
Mirtazapine—ADRA2C—endometrium—uterine cancer	0.000658	0.0147	CbGeAlD
Mirtazapine—ADRA2C—mammalian vulva—uterine cancer	0.000637	0.0142	CbGeAlD
Mirtazapine—CYP2C8—renal system—uterine cancer	0.000631	0.0141	CbGeAlD
Mirtazapine—HTR2B—vagina—uterine cancer	0.000627	0.014	CbGeAlD
Mirtazapine—SLC6A2—female reproductive system—uterine cancer	0.000615	0.0137	CbGeAlD
Mirtazapine—CYP2C8—endometrium—uterine cancer	0.00061	0.0136	CbGeAlD
Mirtazapine—ADRA2C—uterus—uterine cancer	0.000607	0.0135	CbGeAlD
Mirtazapine—HRH1—epithelium—uterine cancer	0.000596	0.0133	CbGeAlD
Mirtazapine—HTR7—female reproductive system—uterine cancer	0.000593	0.0132	CbGeAlD
Mirtazapine—HRH1—uterine cervix—uterine cancer	0.000591	0.0132	CbGeAlD
Mirtazapine—CYP1A2—renal system—uterine cancer	0.000591	0.0132	CbGeAlD
Mirtazapine—ADRA2A—uterine cervix—uterine cancer	0.000581	0.0129	CbGeAlD
Mirtazapine—HRH1—smooth muscle tissue—uterine cancer	0.000575	0.0128	CbGeAlD
Mirtazapine—HRH1—decidua—uterine cancer	0.000563	0.0125	CbGeAlD
Mirtazapine—ADRA2A—decidua—uterine cancer	0.000553	0.0123	CbGeAlD
Mirtazapine—HRH1—endometrium—uterine cancer	0.000535	0.0119	CbGeAlD
Mirtazapine—ADRA2A—endometrium—uterine cancer	0.000525	0.0117	CbGeAlD
Mirtazapine—HRH1—mammalian vulva—uterine cancer	0.000517	0.0115	CbGeAlD
Mirtazapine—ADRA2A—mammalian vulva—uterine cancer	0.000508	0.0113	CbGeAlD
Mirtazapine—CYP2C8—female reproductive system—uterine cancer	0.000506	0.0113	CbGeAlD
Mirtazapine—HTR2A—epithelium—uterine cancer	0.000498	0.0111	CbGeAlD
Mirtazapine—ADRA2C—female gonad—uterine cancer	0.000496	0.0111	CbGeAlD
Mirtazapine—ADRA2C—vagina—uterine cancer	0.000493	0.011	CbGeAlD
Mirtazapine—ADRA2A—uterus—uterine cancer	0.000484	0.0108	CbGeAlD
Mirtazapine—HTR2A—smooth muscle tissue—uterine cancer	0.00048	0.0107	CbGeAlD
Mirtazapine—HTR2A—renal system—uterine cancer	0.000462	0.0103	CbGeAlD
Mirtazapine—CYP2C8—vagina—uterine cancer	0.000457	0.0102	CbGeAlD
Mirtazapine—CYP2C9—female reproductive system—uterine cancer	0.000449	0.01	CbGeAlD
Mirtazapine—HRH1—female reproductive system—uterine cancer	0.000443	0.00987	CbGeAlD
Mirtazapine—ADRA2A—female reproductive system—uterine cancer	0.000435	0.00969	CbGeAlD
Mirtazapine—CYP3A4—renal system—uterine cancer	0.000428	0.00953	CbGeAlD
Mirtazapine—CYP2D6—renal system—uterine cancer	0.000421	0.00937	CbGeAlD
Mirtazapine—HTR2B—lymph node—uterine cancer	0.000405	0.00903	CbGeAlD
Mirtazapine—HRH1—female gonad—uterine cancer	0.000403	0.00898	CbGeAlD
Mirtazapine—HRH1—vagina—uterine cancer	0.000401	0.00892	CbGeAlD
Mirtazapine—ADRA2A—female gonad—uterine cancer	0.000396	0.00882	CbGeAlD
Mirtazapine—ADRA2A—vagina—uterine cancer	0.000393	0.00877	CbGeAlD
Mirtazapine—HTR2A—female reproductive system—uterine cancer	0.00037	0.00824	CbGeAlD
Mirtazapine—SLC6A2—lymph node—uterine cancer	0.00036	0.00802	CbGeAlD
Mirtazapine—CYP3A4—female reproductive system—uterine cancer	0.000342	0.00763	CbGeAlD
Mirtazapine—CYP2D6—female reproductive system—uterine cancer	0.000337	0.00751	CbGeAlD
Mirtazapine—HTR2A—vagina—uterine cancer	0.000335	0.00745	CbGeAlD
Mirtazapine—ADRA2C—lymph node—uterine cancer	0.000319	0.00711	CbGeAlD
Mirtazapine—CYP2D6—female gonad—uterine cancer	0.000307	0.00683	CbGeAlD
Mirtazapine—HRH1—lymph node—uterine cancer	0.000259	0.00577	CbGeAlD
Mirtazapine—ADRA2A—lymph node—uterine cancer	0.000255	0.00567	CbGeAlD
Mirtazapine—Thrombocytopenia—Etoposide—uterine cancer	0.000175	0.000543	CcSEcCtD
Mirtazapine—Tachycardia—Etoposide—uterine cancer	0.000175	0.000541	CcSEcCtD
Mirtazapine—Eosinophilia—Epirubicin—uterine cancer	0.000175	0.000541	CcSEcCtD
Mirtazapine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000174	0.00054	CcSEcCtD
Mirtazapine—Skin disorder—Etoposide—uterine cancer	0.000174	0.000538	CcSEcCtD
Mirtazapine—Dry skin—Doxorubicin—uterine cancer	0.000173	0.000536	CcSEcCtD
Mirtazapine—Hyperhidrosis—Etoposide—uterine cancer	0.000173	0.000536	CcSEcCtD
Mirtazapine—Pancreatitis—Epirubicin—uterine cancer	0.000173	0.000536	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000172	0.000534	CcSEcCtD
Mirtazapine—Angina pectoris—Epirubicin—uterine cancer	0.000172	0.000532	CcSEcCtD
Mirtazapine—Anorexia—Etoposide—uterine cancer	0.00017	0.000528	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00017	0.000527	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00017	0.000527	CcSEcCtD
Mirtazapine—Bronchitis—Epirubicin—uterine cancer	0.00017	0.000525	CcSEcCtD
Mirtazapine—Diarrhoea—Dactinomycin—uterine cancer	0.000169	0.000524	CcSEcCtD
Mirtazapine—Pancytopenia—Epirubicin—uterine cancer	0.000167	0.000519	CcSEcCtD
Mirtazapine—Hypotension—Etoposide—uterine cancer	0.000167	0.000518	CcSEcCtD
Mirtazapine—Gastritis—Doxorubicin—uterine cancer	0.000167	0.000518	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000166	0.000516	CcSEcCtD
Mirtazapine—Muscular weakness—Doxorubicin—uterine cancer	0.000166	0.000516	CcSEcCtD
Mirtazapine—Neutropenia—Epirubicin—uterine cancer	0.000165	0.000511	CcSEcCtD
Mirtazapine—Dysuria—Epirubicin—uterine cancer	0.000165	0.000511	CcSEcCtD
Mirtazapine—Abdominal distension—Doxorubicin—uterine cancer	0.000164	0.000509	CcSEcCtD
Mirtazapine—Influenza—Doxorubicin—uterine cancer	0.000163	0.000506	CcSEcCtD
Mirtazapine—Asthma—Doxorubicin—uterine cancer	0.000163	0.000506	CcSEcCtD
Mirtazapine—Pollakiuria—Epirubicin—uterine cancer	0.000163	0.000505	CcSEcCtD
Mirtazapine—Eosinophilia—Doxorubicin—uterine cancer	0.000161	0.000501	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000161	0.000499	CcSEcCtD
Mirtazapine—Paraesthesia—Etoposide—uterine cancer	0.000161	0.000498	CcSEcCtD
Mirtazapine—Weight increased—Epirubicin—uterine cancer	0.00016	0.000497	CcSEcCtD
Mirtazapine—Pancreatitis—Doxorubicin—uterine cancer	0.00016	0.000496	CcSEcCtD
Mirtazapine—Weight decreased—Epirubicin—uterine cancer	0.000159	0.000494	CcSEcCtD
Mirtazapine—Dyspnoea—Etoposide—uterine cancer	0.000159	0.000494	CcSEcCtD
Mirtazapine—Somnolence—Etoposide—uterine cancer	0.000159	0.000493	CcSEcCtD
Mirtazapine—Angina pectoris—Doxorubicin—uterine cancer	0.000159	0.000492	CcSEcCtD
Mirtazapine—Pneumonia—Epirubicin—uterine cancer	0.000158	0.00049	CcSEcCtD
Mirtazapine—Drowsiness—Epirubicin—uterine cancer	0.000157	0.000487	CcSEcCtD
Mirtazapine—Vomiting—Dactinomycin—uterine cancer	0.000157	0.000487	CcSEcCtD
Mirtazapine—Bronchitis—Doxorubicin—uterine cancer	0.000157	0.000486	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000156	0.000483	CcSEcCtD
Mirtazapine—Rash—Dactinomycin—uterine cancer	0.000156	0.000483	CcSEcCtD
Mirtazapine—Decreased appetite—Etoposide—uterine cancer	0.000155	0.000482	CcSEcCtD
Mirtazapine—Pancytopenia—Doxorubicin—uterine cancer	0.000155	0.00048	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000154	0.000479	CcSEcCtD
Mirtazapine—Fatigue—Etoposide—uterine cancer	0.000154	0.000478	CcSEcCtD
Mirtazapine—Jaundice—Epirubicin—uterine cancer	0.000153	0.000475	CcSEcCtD
Mirtazapine—Stomatitis—Epirubicin—uterine cancer	0.000153	0.000475	CcSEcCtD
Mirtazapine—Constipation—Etoposide—uterine cancer	0.000153	0.000474	CcSEcCtD
Mirtazapine—Pain—Etoposide—uterine cancer	0.000153	0.000474	CcSEcCtD
Mirtazapine—Urinary tract infection—Epirubicin—uterine cancer	0.000153	0.000474	CcSEcCtD
Mirtazapine—Conjunctivitis—Epirubicin—uterine cancer	0.000153	0.000474	CcSEcCtD
Mirtazapine—Dysuria—Doxorubicin—uterine cancer	0.000153	0.000473	CcSEcCtD
Mirtazapine—Neutropenia—Doxorubicin—uterine cancer	0.000153	0.000473	CcSEcCtD
Mirtazapine—Sweating—Epirubicin—uterine cancer	0.000151	0.000467	CcSEcCtD
Mirtazapine—Pollakiuria—Doxorubicin—uterine cancer	0.000151	0.000467	CcSEcCtD
Mirtazapine—Haematuria—Epirubicin—uterine cancer	0.00015	0.000465	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000149	0.000461	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000149	0.000461	CcSEcCtD
Mirtazapine—Weight increased—Doxorubicin—uterine cancer	0.000148	0.00046	CcSEcCtD
Mirtazapine—Epistaxis—Epirubicin—uterine cancer	0.000148	0.00046	CcSEcCtD
Mirtazapine—Weight decreased—Doxorubicin—uterine cancer	0.000148	0.000457	CcSEcCtD
Mirtazapine—Sinusitis—Epirubicin—uterine cancer	0.000147	0.000457	CcSEcCtD
Mirtazapine—Feeling abnormal—Etoposide—uterine cancer	0.000147	0.000457	CcSEcCtD
Mirtazapine—Nausea—Dactinomycin—uterine cancer	0.000147	0.000455	CcSEcCtD
Mirtazapine—Agranulocytosis—Epirubicin—uterine cancer	0.000147	0.000455	CcSEcCtD
Mirtazapine—Pneumonia—Doxorubicin—uterine cancer	0.000146	0.000453	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Etoposide—uterine cancer	0.000146	0.000453	CcSEcCtD
Mirtazapine—Drowsiness—Doxorubicin—uterine cancer	0.000145	0.000451	CcSEcCtD
Mirtazapine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000144	0.000447	CcSEcCtD
Mirtazapine—Bradycardia—Epirubicin—uterine cancer	0.000144	0.000445	CcSEcCtD
Mirtazapine—Urticaria—Etoposide—uterine cancer	0.000142	0.00044	CcSEcCtD
Mirtazapine—Stomatitis—Doxorubicin—uterine cancer	0.000142	0.000439	CcSEcCtD
Mirtazapine—Jaundice—Doxorubicin—uterine cancer	0.000142	0.000439	CcSEcCtD
Mirtazapine—Rhinitis—Epirubicin—uterine cancer	0.000141	0.000438	CcSEcCtD
Mirtazapine—Abdominal pain—Etoposide—uterine cancer	0.000141	0.000438	CcSEcCtD
Mirtazapine—Body temperature increased—Etoposide—uterine cancer	0.000141	0.000438	CcSEcCtD
Mirtazapine—Urinary tract infection—Doxorubicin—uterine cancer	0.000141	0.000438	CcSEcCtD
Mirtazapine—Conjunctivitis—Doxorubicin—uterine cancer	0.000141	0.000438	CcSEcCtD
Mirtazapine—Hepatitis—Epirubicin—uterine cancer	0.000141	0.000437	CcSEcCtD
Mirtazapine—Hypoaesthesia—Epirubicin—uterine cancer	0.00014	0.000435	CcSEcCtD
Mirtazapine—Pharyngitis—Epirubicin—uterine cancer	0.00014	0.000434	CcSEcCtD
Mirtazapine—Sweating—Doxorubicin—uterine cancer	0.000139	0.000432	CcSEcCtD
Mirtazapine—Urinary tract disorder—Epirubicin—uterine cancer	0.000139	0.000432	CcSEcCtD
Mirtazapine—Oedema peripheral—Epirubicin—uterine cancer	0.000139	0.000431	CcSEcCtD
Mirtazapine—Haematuria—Doxorubicin—uterine cancer	0.000139	0.00043	CcSEcCtD
Mirtazapine—Urethral disorder—Epirubicin—uterine cancer	0.000138	0.000429	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000138	0.000426	CcSEcCtD
Mirtazapine—Epistaxis—Doxorubicin—uterine cancer	0.000137	0.000425	CcSEcCtD
Mirtazapine—Sinusitis—Doxorubicin—uterine cancer	0.000136	0.000423	CcSEcCtD
Mirtazapine—Agranulocytosis—Doxorubicin—uterine cancer	0.000136	0.000421	CcSEcCtD
Mirtazapine—Erythema multiforme—Epirubicin—uterine cancer	0.000133	0.000414	CcSEcCtD
Mirtazapine—Bradycardia—Doxorubicin—uterine cancer	0.000133	0.000412	CcSEcCtD
Mirtazapine—Eye disorder—Epirubicin—uterine cancer	0.000132	0.000409	CcSEcCtD
Mirtazapine—Hypersensitivity—Etoposide—uterine cancer	0.000132	0.000408	CcSEcCtD
Mirtazapine—Tinnitus—Epirubicin—uterine cancer	0.000132	0.000408	CcSEcCtD
Mirtazapine—Cardiac disorder—Epirubicin—uterine cancer	0.000131	0.000406	CcSEcCtD
Mirtazapine—Rhinitis—Doxorubicin—uterine cancer	0.000131	0.000406	CcSEcCtD
Mirtazapine—Hepatitis—Doxorubicin—uterine cancer	0.000131	0.000405	CcSEcCtD
Mirtazapine—Hypoaesthesia—Doxorubicin—uterine cancer	0.00013	0.000403	CcSEcCtD
Mirtazapine—Pharyngitis—Doxorubicin—uterine cancer	0.00013	0.000402	CcSEcCtD
Mirtazapine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000129	0.0004	CcSEcCtD
Mirtazapine—Oedema peripheral—Doxorubicin—uterine cancer	0.000129	0.000399	CcSEcCtD
Mirtazapine—Asthenia—Etoposide—uterine cancer	0.000128	0.000398	CcSEcCtD
Mirtazapine—Angiopathy—Epirubicin—uterine cancer	0.000128	0.000397	CcSEcCtD
Mirtazapine—Urethral disorder—Doxorubicin—uterine cancer	0.000128	0.000397	CcSEcCtD
Mirtazapine—Chills—Epirubicin—uterine cancer	0.000127	0.000392	CcSEcCtD
Mirtazapine—Pruritus—Etoposide—uterine cancer	0.000127	0.000392	CcSEcCtD
Mirtazapine—Arrhythmia—Epirubicin—uterine cancer	0.000126	0.000391	CcSEcCtD
Mirtazapine—Alopecia—Epirubicin—uterine cancer	0.000125	0.000386	CcSEcCtD
Mirtazapine—Mental disorder—Epirubicin—uterine cancer	0.000124	0.000383	CcSEcCtD
Mirtazapine—Erythema multiforme—Doxorubicin—uterine cancer	0.000123	0.000383	CcSEcCtD
Mirtazapine—Malnutrition—Epirubicin—uterine cancer	0.000123	0.000381	CcSEcCtD
Mirtazapine—Diarrhoea—Etoposide—uterine cancer	0.000122	0.000379	CcSEcCtD
Mirtazapine—Eye disorder—Doxorubicin—uterine cancer	0.000122	0.000378	CcSEcCtD
Mirtazapine—Tinnitus—Doxorubicin—uterine cancer	0.000122	0.000377	CcSEcCtD
Mirtazapine—Cardiac disorder—Doxorubicin—uterine cancer	0.000121	0.000376	CcSEcCtD
Mirtazapine—Flatulence—Epirubicin—uterine cancer	0.000121	0.000375	CcSEcCtD
Mirtazapine—Tension—Epirubicin—uterine cancer	0.000121	0.000374	CcSEcCtD
Mirtazapine—Dysgeusia—Epirubicin—uterine cancer	0.00012	0.000373	CcSEcCtD
Mirtazapine—Nervousness—Epirubicin—uterine cancer	0.000119	0.00037	CcSEcCtD
Mirtazapine—Back pain—Epirubicin—uterine cancer	0.000119	0.000368	CcSEcCtD
Mirtazapine—Angiopathy—Doxorubicin—uterine cancer	0.000118	0.000367	CcSEcCtD
Mirtazapine—Dizziness—Etoposide—uterine cancer	0.000118	0.000367	CcSEcCtD
Mirtazapine—Chills—Doxorubicin—uterine cancer	0.000117	0.000363	CcSEcCtD
Mirtazapine—Arrhythmia—Doxorubicin—uterine cancer	0.000117	0.000362	CcSEcCtD
Mirtazapine—Alopecia—Doxorubicin—uterine cancer	0.000115	0.000358	CcSEcCtD
Mirtazapine—Mental disorder—Doxorubicin—uterine cancer	0.000114	0.000355	CcSEcCtD
Mirtazapine—Ill-defined disorder—Epirubicin—uterine cancer	0.000114	0.000353	CcSEcCtD
Mirtazapine—Vomiting—Etoposide—uterine cancer	0.000114	0.000352	CcSEcCtD
Mirtazapine—Malnutrition—Doxorubicin—uterine cancer	0.000114	0.000352	CcSEcCtD
Mirtazapine—Anaemia—Epirubicin—uterine cancer	0.000114	0.000352	CcSEcCtD
Mirtazapine—Agitation—Epirubicin—uterine cancer	0.000113	0.00035	CcSEcCtD
Mirtazapine—Rash—Etoposide—uterine cancer	0.000113	0.00035	CcSEcCtD
Mirtazapine—Dermatitis—Etoposide—uterine cancer	0.000113	0.000349	CcSEcCtD
Mirtazapine—Headache—Etoposide—uterine cancer	0.000112	0.000347	CcSEcCtD
Mirtazapine—Flatulence—Doxorubicin—uterine cancer	0.000112	0.000347	CcSEcCtD
Mirtazapine—Tension—Doxorubicin—uterine cancer	0.000112	0.000346	CcSEcCtD
Mirtazapine—Dysgeusia—Doxorubicin—uterine cancer	0.000111	0.000345	CcSEcCtD
Mirtazapine—Malaise—Epirubicin—uterine cancer	0.000111	0.000343	CcSEcCtD
Mirtazapine—Nervousness—Doxorubicin—uterine cancer	0.00011	0.000342	CcSEcCtD
Mirtazapine—Vertigo—Epirubicin—uterine cancer	0.00011	0.000342	CcSEcCtD
Mirtazapine—Syncope—Epirubicin—uterine cancer	0.00011	0.000341	CcSEcCtD
Mirtazapine—Leukopenia—Epirubicin—uterine cancer	0.00011	0.000341	CcSEcCtD
Mirtazapine—Back pain—Doxorubicin—uterine cancer	0.00011	0.000341	CcSEcCtD
Mirtazapine—Palpitations—Epirubicin—uterine cancer	0.000109	0.000336	CcSEcCtD
Mirtazapine—Loss of consciousness—Epirubicin—uterine cancer	0.000108	0.000335	CcSEcCtD
Mirtazapine—Cough—Epirubicin—uterine cancer	0.000107	0.000332	CcSEcCtD
Mirtazapine—Convulsion—Epirubicin—uterine cancer	0.000106	0.00033	CcSEcCtD
Mirtazapine—Nausea—Etoposide—uterine cancer	0.000106	0.000329	CcSEcCtD
Mirtazapine—Hypertension—Epirubicin—uterine cancer	0.000106	0.000329	CcSEcCtD
Mirtazapine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000105	0.000327	CcSEcCtD
Mirtazapine—Anaemia—Doxorubicin—uterine cancer	0.000105	0.000326	CcSEcCtD
Mirtazapine—Arthralgia—Epirubicin—uterine cancer	0.000105	0.000324	CcSEcCtD
Mirtazapine—Chest pain—Epirubicin—uterine cancer	0.000105	0.000324	CcSEcCtD
Mirtazapine—Myalgia—Epirubicin—uterine cancer	0.000105	0.000324	CcSEcCtD
Mirtazapine—Agitation—Doxorubicin—uterine cancer	0.000104	0.000324	CcSEcCtD
Mirtazapine—Anxiety—Epirubicin—uterine cancer	0.000104	0.000323	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000104	0.000322	CcSEcCtD
Mirtazapine—Discomfort—Epirubicin—uterine cancer	0.000103	0.00032	CcSEcCtD
Mirtazapine—Malaise—Doxorubicin—uterine cancer	0.000102	0.000318	CcSEcCtD
Mirtazapine—Dry mouth—Epirubicin—uterine cancer	0.000102	0.000317	CcSEcCtD
Mirtazapine—Vertigo—Doxorubicin—uterine cancer	0.000102	0.000316	CcSEcCtD
Mirtazapine—Syncope—Doxorubicin—uterine cancer	0.000102	0.000316	CcSEcCtD
Mirtazapine—Leukopenia—Doxorubicin—uterine cancer	0.000102	0.000315	CcSEcCtD
Mirtazapine—Confusional state—Epirubicin—uterine cancer	0.000101	0.000313	CcSEcCtD
Mirtazapine—Palpitations—Doxorubicin—uterine cancer	0.0001	0.000311	CcSEcCtD
Mirtazapine—Oedema—Epirubicin—uterine cancer	0.0001	0.000311	CcSEcCtD
Mirtazapine—Loss of consciousness—Doxorubicin—uterine cancer	9.99e-05	0.00031	CcSEcCtD
Mirtazapine—Infection—Epirubicin—uterine cancer	9.96e-05	0.000309	CcSEcCtD
Mirtazapine—Cough—Doxorubicin—uterine cancer	9.92e-05	0.000307	CcSEcCtD
Mirtazapine—Shock—Epirubicin—uterine cancer	9.86e-05	0.000306	CcSEcCtD
Mirtazapine—Convulsion—Doxorubicin—uterine cancer	9.85e-05	0.000305	CcSEcCtD
Mirtazapine—Nervous system disorder—Epirubicin—uterine cancer	9.83e-05	0.000305	CcSEcCtD
Mirtazapine—Thrombocytopenia—Epirubicin—uterine cancer	9.81e-05	0.000304	CcSEcCtD
Mirtazapine—Hypertension—Doxorubicin—uterine cancer	9.81e-05	0.000304	CcSEcCtD
Mirtazapine—Tachycardia—Epirubicin—uterine cancer	9.78e-05	0.000303	CcSEcCtD
Mirtazapine—Skin disorder—Epirubicin—uterine cancer	9.74e-05	0.000302	CcSEcCtD
Mirtazapine—Hyperhidrosis—Epirubicin—uterine cancer	9.69e-05	0.0003	CcSEcCtD
Mirtazapine—Arthralgia—Doxorubicin—uterine cancer	9.68e-05	0.0003	CcSEcCtD
Mirtazapine—Chest pain—Doxorubicin—uterine cancer	9.68e-05	0.0003	CcSEcCtD
Mirtazapine—Myalgia—Doxorubicin—uterine cancer	9.68e-05	0.0003	CcSEcCtD
Mirtazapine—Anxiety—Doxorubicin—uterine cancer	9.64e-05	0.000299	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	9.61e-05	0.000298	CcSEcCtD
Mirtazapine—Discomfort—Doxorubicin—uterine cancer	9.56e-05	0.000296	CcSEcCtD
Mirtazapine—Anorexia—Epirubicin—uterine cancer	9.55e-05	0.000296	CcSEcCtD
Mirtazapine—Dry mouth—Doxorubicin—uterine cancer	9.46e-05	0.000293	CcSEcCtD
Mirtazapine—Hypotension—Epirubicin—uterine cancer	9.37e-05	0.00029	CcSEcCtD
Mirtazapine—Confusional state—Doxorubicin—uterine cancer	9.35e-05	0.00029	CcSEcCtD
Mirtazapine—Oedema—Doxorubicin—uterine cancer	9.27e-05	0.000288	CcSEcCtD
Mirtazapine—Infection—Doxorubicin—uterine cancer	9.21e-05	0.000286	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.13e-05	0.000283	CcSEcCtD
Mirtazapine—Shock—Doxorubicin—uterine cancer	9.12e-05	0.000283	CcSEcCtD
Mirtazapine—Nervous system disorder—Doxorubicin—uterine cancer	9.1e-05	0.000282	CcSEcCtD
Mirtazapine—Thrombocytopenia—Doxorubicin—uterine cancer	9.08e-05	0.000281	CcSEcCtD
Mirtazapine—Insomnia—Epirubicin—uterine cancer	9.07e-05	0.000281	CcSEcCtD
Mirtazapine—Tachycardia—Doxorubicin—uterine cancer	9.05e-05	0.000281	CcSEcCtD
Mirtazapine—Skin disorder—Doxorubicin—uterine cancer	9.01e-05	0.000279	CcSEcCtD
Mirtazapine—Paraesthesia—Epirubicin—uterine cancer	9e-05	0.000279	CcSEcCtD
Mirtazapine—Hyperhidrosis—Doxorubicin—uterine cancer	8.97e-05	0.000278	CcSEcCtD
Mirtazapine—Dyspnoea—Epirubicin—uterine cancer	8.94e-05	0.000277	CcSEcCtD
Mirtazapine—Somnolence—Epirubicin—uterine cancer	8.91e-05	0.000276	CcSEcCtD
Mirtazapine—Anorexia—Doxorubicin—uterine cancer	8.84e-05	0.000274	CcSEcCtD
Mirtazapine—Dyspepsia—Epirubicin—uterine cancer	8.82e-05	0.000274	CcSEcCtD
Mirtazapine—Decreased appetite—Epirubicin—uterine cancer	8.71e-05	0.00027	CcSEcCtD
Mirtazapine—Hypotension—Doxorubicin—uterine cancer	8.67e-05	0.000269	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Epirubicin—uterine cancer	8.65e-05	0.000268	CcSEcCtD
Mirtazapine—Fatigue—Epirubicin—uterine cancer	8.64e-05	0.000268	CcSEcCtD
Mirtazapine—Constipation—Epirubicin—uterine cancer	8.57e-05	0.000266	CcSEcCtD
Mirtazapine—Pain—Epirubicin—uterine cancer	8.57e-05	0.000266	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.45e-05	0.000262	CcSEcCtD
Mirtazapine—Insomnia—Doxorubicin—uterine cancer	8.39e-05	0.00026	CcSEcCtD
Mirtazapine—Paraesthesia—Doxorubicin—uterine cancer	8.33e-05	0.000258	CcSEcCtD
Mirtazapine—Dyspnoea—Doxorubicin—uterine cancer	8.27e-05	0.000256	CcSEcCtD
Mirtazapine—Feeling abnormal—Epirubicin—uterine cancer	8.26e-05	0.000256	CcSEcCtD
Mirtazapine—Somnolence—Doxorubicin—uterine cancer	8.25e-05	0.000256	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Epirubicin—uterine cancer	8.2e-05	0.000254	CcSEcCtD
Mirtazapine—Dyspepsia—Doxorubicin—uterine cancer	8.16e-05	0.000253	CcSEcCtD
Mirtazapine—Decreased appetite—Doxorubicin—uterine cancer	8.06e-05	0.00025	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Doxorubicin—uterine cancer	8.01e-05	0.000248	CcSEcCtD
Mirtazapine—Fatigue—Doxorubicin—uterine cancer	8e-05	0.000248	CcSEcCtD
Mirtazapine—Urticaria—Epirubicin—uterine cancer	7.96e-05	0.000247	CcSEcCtD
Mirtazapine—Pain—Doxorubicin—uterine cancer	7.93e-05	0.000246	CcSEcCtD
Mirtazapine—Constipation—Doxorubicin—uterine cancer	7.93e-05	0.000246	CcSEcCtD
Mirtazapine—Abdominal pain—Epirubicin—uterine cancer	7.92e-05	0.000246	CcSEcCtD
Mirtazapine—Body temperature increased—Epirubicin—uterine cancer	7.92e-05	0.000246	CcSEcCtD
Mirtazapine—Feeling abnormal—Doxorubicin—uterine cancer	7.64e-05	0.000237	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Doxorubicin—uterine cancer	7.58e-05	0.000235	CcSEcCtD
Mirtazapine—Hypersensitivity—Epirubicin—uterine cancer	7.39e-05	0.000229	CcSEcCtD
Mirtazapine—Urticaria—Doxorubicin—uterine cancer	7.37e-05	0.000228	CcSEcCtD
Mirtazapine—Abdominal pain—Doxorubicin—uterine cancer	7.33e-05	0.000227	CcSEcCtD
Mirtazapine—Body temperature increased—Doxorubicin—uterine cancer	7.33e-05	0.000227	CcSEcCtD
Mirtazapine—Asthenia—Epirubicin—uterine cancer	7.19e-05	0.000223	CcSEcCtD
Mirtazapine—Pruritus—Epirubicin—uterine cancer	7.09e-05	0.00022	CcSEcCtD
Mirtazapine—Diarrhoea—Epirubicin—uterine cancer	6.86e-05	0.000213	CcSEcCtD
Mirtazapine—Hypersensitivity—Doxorubicin—uterine cancer	6.83e-05	0.000212	CcSEcCtD
Mirtazapine—Asthenia—Doxorubicin—uterine cancer	6.65e-05	0.000206	CcSEcCtD
Mirtazapine—Dizziness—Epirubicin—uterine cancer	6.63e-05	0.000205	CcSEcCtD
Mirtazapine—Pruritus—Doxorubicin—uterine cancer	6.56e-05	0.000203	CcSEcCtD
Mirtazapine—Vomiting—Epirubicin—uterine cancer	6.37e-05	0.000198	CcSEcCtD
Mirtazapine—Diarrhoea—Doxorubicin—uterine cancer	6.35e-05	0.000197	CcSEcCtD
Mirtazapine—Rash—Epirubicin—uterine cancer	6.32e-05	0.000196	CcSEcCtD
Mirtazapine—Dermatitis—Epirubicin—uterine cancer	6.31e-05	0.000196	CcSEcCtD
Mirtazapine—Headache—Epirubicin—uterine cancer	6.28e-05	0.000195	CcSEcCtD
Mirtazapine—Dizziness—Doxorubicin—uterine cancer	6.13e-05	0.00019	CcSEcCtD
Mirtazapine—Nausea—Epirubicin—uterine cancer	5.95e-05	0.000185	CcSEcCtD
Mirtazapine—Vomiting—Doxorubicin—uterine cancer	5.9e-05	0.000183	CcSEcCtD
Mirtazapine—Rash—Doxorubicin—uterine cancer	5.85e-05	0.000181	CcSEcCtD
Mirtazapine—Dermatitis—Doxorubicin—uterine cancer	5.84e-05	0.000181	CcSEcCtD
Mirtazapine—Headache—Doxorubicin—uterine cancer	5.81e-05	0.00018	CcSEcCtD
Mirtazapine—Nausea—Doxorubicin—uterine cancer	5.51e-05	0.000171	CcSEcCtD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.67e-06	0.000188	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CTNNB1—uterine cancer	2.66e-06	0.000187	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EP300—uterine cancer	2.66e-06	0.000187	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ERBB2—uterine cancer	2.65e-06	0.000187	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—VEGFA—uterine cancer	2.64e-06	0.000186	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ERBB2—uterine cancer	2.64e-06	0.000186	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.64e-06	0.000185	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CXCL8—uterine cancer	2.63e-06	0.000185	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTEN—uterine cancer	2.62e-06	0.000184	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—PIK3CA—uterine cancer	2.62e-06	0.000184	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HRAS—uterine cancer	2.61e-06	0.000184	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—PIK3CA—uterine cancer	2.61e-06	0.000184	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—NRAS—uterine cancer	2.61e-06	0.000183	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PTEN—uterine cancer	2.6e-06	0.000183	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—KRAS—uterine cancer	2.58e-06	0.000182	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CXCL8—uterine cancer	2.57e-06	0.000181	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.57e-06	0.000181	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CDKN1B—uterine cancer	2.57e-06	0.000181	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ERBB2—uterine cancer	2.57e-06	0.000181	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	2.57e-06	0.00018	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HRAS—uterine cancer	2.56e-06	0.00018	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—AKT1—uterine cancer	2.54e-06	0.000179	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—KRAS—uterine cancer	2.54e-06	0.000179	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—KRAS—uterine cancer	2.54e-06	0.000178	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—AKT1—uterine cancer	2.53e-06	0.000178	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—VEGFA—uterine cancer	2.52e-06	0.000177	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—PIK3CA—uterine cancer	2.52e-06	0.000177	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CXCL8—uterine cancer	2.52e-06	0.000177	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.51e-06	0.000177	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CDKN1B—uterine cancer	2.51e-06	0.000177	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CXCL8—uterine cancer	2.5e-06	0.000176	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL2—uterine cancer	2.5e-06	0.000176	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HRAS—uterine cancer	2.5e-06	0.000176	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—EP300—uterine cancer	2.5e-06	0.000176	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—MTHFR—uterine cancer	2.49e-06	0.000175	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—NRAS—uterine cancer	2.49e-06	0.000175	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—KRAS—uterine cancer	2.49e-06	0.000175	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HRAS—uterine cancer	2.49e-06	0.000175	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AKT1—uterine cancer	2.49e-06	0.000175	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EP300—uterine cancer	2.48e-06	0.000174	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—MTHFR—uterine cancer	2.47e-06	0.000174	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	2.46e-06	0.000173	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	2.45e-06	0.000172	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CXCL8—uterine cancer	2.44e-06	0.000171	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	2.43e-06	0.000171	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CTNNB1—uterine cancer	2.43e-06	0.000171	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HRAS—uterine cancer	2.42e-06	0.00017	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	2.42e-06	0.00017	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KRAS—uterine cancer	2.38e-06	0.000167	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CDKN1B—uterine cancer	2.38e-06	0.000167	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CTNNB1—uterine cancer	2.37e-06	0.000167	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	2.37e-06	0.000167	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PTEN—uterine cancer	2.37e-06	0.000166	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AKT1—uterine cancer	2.35e-06	0.000165	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—uterine cancer	2.35e-06	0.000165	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KRAS—uterine cancer	2.34e-06	0.000165	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—PIK3CA—uterine cancer	2.34e-06	0.000164	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	2.33e-06	0.000164	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ERBB2—uterine cancer	2.33e-06	0.000164	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	2.33e-06	0.000164	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	2.32e-06	0.000163	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NRAS—uterine cancer	2.32e-06	0.000163	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PTEN—uterine cancer	2.31e-06	0.000163	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—KRAS—uterine cancer	2.31e-06	0.000163	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	2.31e-06	0.000162	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AKT1—uterine cancer	2.31e-06	0.000162	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ERBB2—uterine cancer	2.29e-06	0.000161	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ERBB2—uterine cancer	2.29e-06	0.000161	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—PIK3CA—uterine cancer	2.29e-06	0.000161	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PTEN—uterine cancer	2.26e-06	0.000159	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AKT1—uterine cancer	2.26e-06	0.000159	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EP300—uterine cancer	2.26e-06	0.000159	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PTEN—uterine cancer	2.25e-06	0.000158	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CTNNB1—uterine cancer	2.25e-06	0.000158	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ERBB2—uterine cancer	2.24e-06	0.000158	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KRAS—uterine cancer	2.24e-06	0.000158	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—uterine cancer	2.21e-06	0.000155	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—uterine cancer	2.21e-06	0.000155	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EP300—uterine cancer	2.21e-06	0.000155	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	2.2e-06	0.000154	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HRAS—uterine cancer	2.2e-06	0.000154	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTEN—uterine cancer	2.19e-06	0.000154	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PIK3CA—uterine cancer	2.19e-06	0.000154	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.18e-06	0.000153	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	2.17e-06	0.000153	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—uterine cancer	2.17e-06	0.000153	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—STK11—uterine cancer	2.17e-06	0.000152	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.17e-06	0.000152	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	2.16e-06	0.000152	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EP300—uterine cancer	2.16e-06	0.000152	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	2.16e-06	0.000152	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HRAS—uterine cancer	2.16e-06	0.000152	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PIK3CA—uterine cancer	2.15e-06	0.000151	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EP300—uterine cancer	2.15e-06	0.000151	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—uterine cancer	2.14e-06	0.000151	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—uterine cancer	2.14e-06	0.00015	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—uterine cancer	2.14e-06	0.00015	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	2.13e-06	0.00015	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—uterine cancer	2.13e-06	0.00015	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTEN—uterine cancer	2.13e-06	0.00015	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PIK3CA—uterine cancer	2.12e-06	0.000149	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	2.12e-06	0.000149	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	2.12e-06	0.000149	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—uterine cancer	2.12e-06	0.000149	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HRAS—uterine cancer	2.12e-06	0.000149	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NRAS—uterine cancer	2.11e-06	0.000148	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—MTHFR—uterine cancer	2.11e-06	0.000148	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	2.1e-06	0.000148	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	2.1e-06	0.000147	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—uterine cancer	2.09e-06	0.000147	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EP300—uterine cancer	2.09e-06	0.000147	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB2—uterine cancer	2.09e-06	0.000147	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—uterine cancer	2.08e-06	0.000147	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CDKN1B—uterine cancer	2.08e-06	0.000146	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NRAS—uterine cancer	2.06e-06	0.000145	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—uterine cancer	2.06e-06	0.000145	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—uterine cancer	2.06e-06	0.000145	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—uterine cancer	2.04e-06	0.000144	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	2.04e-06	0.000143	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	2.03e-06	0.000143	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—EP300—uterine cancer	2.03e-06	0.000143	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HRAS—uterine cancer	2.02e-06	0.000142	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NRAS—uterine cancer	2.02e-06	0.000142	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NRAS—uterine cancer	2.01e-06	0.000141	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	2.01e-06	0.000141	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	2e-06	0.000141	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—uterine cancer	2e-06	0.00014	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—uterine cancer	1.99e-06	0.00014	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HRAS—uterine cancer	1.99e-06	0.00014	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—uterine cancer	1.99e-06	0.00014	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—uterine cancer	1.98e-06	0.000139	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—uterine cancer	1.98e-06	0.000139	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—uterine cancer	1.97e-06	0.000138	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HRAS—uterine cancer	1.97e-06	0.000138	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—uterine cancer	1.96e-06	0.000138	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—uterine cancer	1.96e-06	0.000137	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NRAS—uterine cancer	1.95e-06	0.000137	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—uterine cancer	1.95e-06	0.000137	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—uterine cancer	1.94e-06	0.000136	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CDKN1B—uterine cancer	1.93e-06	0.000136	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—uterine cancer	1.91e-06	0.000135	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—uterine cancer	1.91e-06	0.000134	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HRAS—uterine cancer	1.91e-06	0.000134	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	1.91e-06	0.000134	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—uterine cancer	1.9e-06	0.000134	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—uterine cancer	1.9e-06	0.000134	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EP300—uterine cancer	1.89e-06	0.000133	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—uterine cancer	1.87e-06	0.000131	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EP300—uterine cancer	1.86e-06	0.000131	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EP300—uterine cancer	1.86e-06	0.000131	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.86e-06	0.000131	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—uterine cancer	1.85e-06	0.00013	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—uterine cancer	1.83e-06	0.000129	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EP300—uterine cancer	1.83e-06	0.000128	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—uterine cancer	1.82e-06	0.000128	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HRAS—uterine cancer	1.82e-06	0.000128	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—uterine cancer	1.82e-06	0.000128	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—uterine cancer	1.79e-06	0.000126	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—uterine cancer	1.79e-06	0.000126	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—uterine cancer	1.78e-06	0.000125	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—uterine cancer	1.78e-06	0.000125	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NRAS—uterine cancer	1.77e-06	0.000125	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—uterine cancer	1.77e-06	0.000125	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	1.77e-06	0.000124	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—uterine cancer	1.76e-06	0.000124	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—uterine cancer	1.76e-06	0.000124	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NRAS—uterine cancer	1.74e-06	0.000123	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NRAS—uterine cancer	1.74e-06	0.000122	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—uterine cancer	1.74e-06	0.000122	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—uterine cancer	1.74e-06	0.000122	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—uterine cancer	1.73e-06	0.000122	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—uterine cancer	1.73e-06	0.000122	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NRAS—uterine cancer	1.71e-06	0.00012	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EP300—uterine cancer	1.7e-06	0.000119	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HRAS—uterine cancer	1.69e-06	0.000119	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—uterine cancer	1.69e-06	0.000119	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—uterine cancer	1.68e-06	0.000118	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—uterine cancer	1.68e-06	0.000118	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—uterine cancer	1.67e-06	0.000117	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—uterine cancer	1.63e-06	0.000115	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—MTHFR—uterine cancer	1.63e-06	0.000115	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—uterine cancer	1.61e-06	0.000114	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—EP300—uterine cancer	1.61e-06	0.000113	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—uterine cancer	1.61e-06	0.000113	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—uterine cancer	1.61e-06	0.000113	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	1.6e-06	0.000112	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	1.59e-06	0.000112	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NRAS—uterine cancer	1.59e-06	0.000112	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—uterine cancer	1.58e-06	0.000111	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—uterine cancer	1.54e-06	0.000109	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—uterine cancer	1.54e-06	0.000109	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HRAS—uterine cancer	1.54e-06	0.000109	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—uterine cancer	1.54e-06	0.000108	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—uterine cancer	1.53e-06	0.000107	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HRAS—uterine cancer	1.51e-06	0.000106	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—uterine cancer	1.51e-06	0.000106	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—uterine cancer	1.5e-06	0.000106	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—uterine cancer	1.5e-06	0.000106	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—uterine cancer	1.5e-06	0.000105	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—uterine cancer	1.5e-06	0.000105	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—uterine cancer	1.49e-06	0.000105	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HRAS—uterine cancer	1.48e-06	0.000104	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—uterine cancer	1.47e-06	0.000103	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HRAS—uterine cancer	1.47e-06	0.000103	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HRAS—uterine cancer	1.43e-06	0.0001	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	1.4e-06	9.86e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—uterine cancer	1.39e-06	9.75e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	1.38e-06	9.7e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	1.38e-06	9.68e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—uterine cancer	1.37e-06	9.66e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—uterine cancer	1.37e-06	9.6e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—uterine cancer	1.36e-06	9.59e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—uterine cancer	1.36e-06	9.53e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—uterine cancer	1.35e-06	9.5e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—uterine cancer	1.33e-06	9.38e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—uterine cancer	1.33e-06	9.38e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—uterine cancer	1.33e-06	9.36e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—EP300—uterine cancer	1.32e-06	9.29e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—EP300—uterine cancer	1.31e-06	9.21e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—uterine cancer	1.31e-06	9.19e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—uterine cancer	1.3e-06	9.17e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—uterine cancer	1.3e-06	9.12e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HRAS—uterine cancer	1.3e-06	9.12e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HRAS—uterine cancer	1.28e-06	8.97e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HRAS—uterine cancer	1.27e-06	8.95e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—uterine cancer	1.26e-06	8.87e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—uterine cancer	1.25e-06	8.82e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HRAS—uterine cancer	1.25e-06	8.79e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—uterine cancer	1.23e-06	8.62e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—uterine cancer	1.21e-06	8.54e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.19e-06	8.38e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—uterine cancer	1.17e-06	8.26e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HRAS—uterine cancer	1.16e-06	8.16e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—uterine cancer	1.15e-06	8.05e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—uterine cancer	1.13e-06	7.92e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—uterine cancer	1.12e-06	7.91e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—EP300—uterine cancer	1.12e-06	7.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—uterine cancer	1.1e-06	7.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—uterine cancer	1.03e-06	7.21e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—uterine cancer	9.78e-07	6.88e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—uterine cancer	9.73e-07	6.84e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—uterine cancer	9.69e-07	6.82e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—uterine cancer	9.06e-07	6.37e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—EP300—uterine cancer	8.64e-07	6.08e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—uterine cancer	8.28e-07	5.82e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—uterine cancer	7.99e-07	5.62e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—uterine cancer	7.92e-07	5.57e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—uterine cancer	6.77e-07	4.76e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—uterine cancer	6.39e-07	4.5e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—uterine cancer	5.22e-07	3.67e-05	CbGpPWpGaD
